Antigene Radiotherapy: Targeted Radiodamage with 125I-Labeled Triplex-Forming Oligonucleotides

Annals of the New York Academy of Sciences

Volumn 1002, Issue , 2003, Pages 134-140

  Panyutin, I G ^a,b   Sedelnikova, O A ^a   Karamychev, V N ^a   Neumann, R D ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Gene targeting; Iodine 125; Oligonucleotides; Radiotherapy; Triple helix

Indexed keywords

IODINE 125; MULTIDRUG RESISTANCE PROTEIN 1; OLIGONUCLEOTIDE;

ANTIGENE RADIOTHERAPY; AUGER ELECTRON SPECTROSCOPY; BINDING SITE; CELL HYBRIDIZATION; CELL LINE; CELL MEMBRANE PERMEABILITY; COMPLEX FORMATION; CONFERENCE PAPER; CONJUGATION; CYTOPLASM; DNA BINDING; DNA DEGRADATION; DNA FLANKING REGION; DNA PROBE; DNA PURIFICATION; DNA SEQUENCE; DRUG DELIVERY SYSTEM; DRUG TARGETING; ELECTRON RADIATION; ELECTRON TRANSPORT; GENE; GENE LOCATION; GENE TARGETING; GENE THERAPY; HUMAN; INTRON; ISOTOPE LABELING; MOLECULAR MECHANICS; MULTIDRUG RESISTANCE PROTEIN 1 GENE; RADIATION DOSE; RADIATION INJURY; SOUTHERN BLOTTING;

EID: 1342268520     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1281.012     Document Type: Conference Paper

References (20)

1. PANYUTIN, I.G. et al. 2000. Development of DNA-based radiopharmaceuticals carrying Auger-electron emitters for anti-gene radiotherapy. Q. J. Nucl. Med. 44: 256-267.
2. FEINENDEGEN, L.E. 1975. Biological damage from the Auger effect, possible benefits. Radiat. Environ. Biophys. 12: 85-99.
3. LOBACHEVSKY, P.N. & R.F. MARTIN. 2000. Iodine-125 decay in a synthetic oligodeoxynucleotide. I. Fragment size distribution and evaluation of breakage probability. Radiat. Res. 153: 263-270.
4. HELENE, C. 1991. The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides. Anticancer Drug Des. 6: 569-584.
5. BELOUSOV, E.S. et al. 1998. Triplex targeting of a native gene in permeabilized intact cells: covalent modification of the gene for the chemokine receptor CCR5. Nucleic Acids Res. 26: 1324-1328.
6. MAJUMDAR, A. et al. 1998. Targeted gene knockout mediated by triple helix forming oligonucleotides. Nat. Genet. 20: 212-214.
7. GOTTESMAN, M.M. & I. PASTAN. 1993. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62: 385-427.
8. FOJO, A.T. et al. 1985. Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells. Proc. Natl. Acad. Sci. USA 82: 7661-7665.
9. PANYUTIN, I.G. & R.D. NEUMANN. 1996. Sequence-specific DNA breaks produced by triplex-directed decay of iodine-125. Acta Oncol. 35: 817-823.
10. 125I-labeled triplex-forming oligonucleotides. Antisense Nucleic Acid Drug Dev. 10: 443-452.
11. SEDELNIKOVA, O.A. et al. 2001. Development of DNA-based radiopharmaceuticals carrying Auger-electron emitters for antigene radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 49: 391-396.
12. 125I labeled oligonucleotides. Nucleic Acids Res. 22: 4979-4982.
13. 125I incorporated into a triplex-forming oligonucleotide correlates with geometry of the triplex. Nucleic Acids Res. 25: 883-887.
14. MATTAJ, I.W. & L. ENGLMEIER. 1998. Nucleocytoplasmic transport: the soluble phase. Annu. Rev. Biochem. 67: 265-306.
15. FISHER, T.L. et al. 1993. Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells. Nucleic Acids Res. 21: 3857-3865.
16. SEDELNIKOVA, O.A. et al. 1998. Radiotoxicity of iodine-125-labeled oligodeoxyribonucleotides in mammalian cells. J. Nucl. Med. 39: 1412-1418.
17. ZANTA, M.A., P. BELGUISE-VALLADIER & J.P. BEHR. 1999. Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. USA 96: 91-96.
18. GESELOWITZ, D.A. & L.M. NECKERS. 1992. Analysis of oligonucleotide binding, internalization, and intracellular trafficking utilizing a novel radiolabeled crosslinker. Antisense Res. Dev. 2: 17-25.
19. RYKOVA, E. et al. 1994. Serum immunoglobulins interact with oligonucleotides. FEBS Lett. 344: 96-98.
20. 125I-labeled triplex-forming oligonucleotides conjugated with nuclear localization signal peptide. Antisense Nucleic Acid Drug Dev. 12: 43-49.